Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation.
Maccherini
M
M
Institute of Thoracic and Cardiovascular Surgery, University of Siena, Hospital Le Scotte, Italy.
Bernazzali
S
S
Diciolla
F
F
Giunti
G
G
Bizzarri
F
F
Lisi
G F
GF
Davoli
G
G
Biagioli
B
B
Giomarelli
P P
PP
Simeone
F
F
Caciorgna
M
M
Marchetti
L
L
Pula
G
G
Sani
G
G
Toscano
M
M
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D011241:Prednisone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone